David Erritzoe1, William A Richards2. 1. a Centre for Psychiatry , Neuropsychopharmacology Unit, Division of Brain Sciences, Department of Medicine, Imperial College London , London W12 0NN , UK. 2. b Department of Psychiatry , Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Authors: Joost J Breeksema; Bouwe W Kuin; Jeanine Kamphuis; Wim van den Brink; Eric Vermetten; Robert A Schoevers Journal: J Psychopharmacol Date: 2022-08-26 Impact factor: 4.562